sCD163 and sMR were not developed with the purpose of fibrosis detection, but are functional markers of macrophage activation, and have been associated with liver fibrosis reflecting the roles of macrophages in liver disease and fibrogenesis (10). This evidence concerns the gene LYPD4 and Hepatic fibrosis.